Remetinostat

Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma.


Cat. No.: EX-A3219	Purity: >98%

	Chemical structure of Remetinostat

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
100mg	450	In-stock
200mg	550	In-stock
500mg	750	In-stock
1g	1050	In-stock
5g	2985	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	SHP-141
CAS No.	946150-57-8
Purity	>98%
Formula	C16H21NO6
Mol Weight	323.341
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Yijun Deng, et al. Process Development of the Soft Histone Deacetylate Enzyme Inhibitor SHP-141: Acylation of Methyl Paraben and Suberyl Hydroxamic Acid Formation. Org. Process Res. Dev. 2016, 20, 10, 1812-1820.
CoA	CoA of Remetinostat

Smiles:	O=C(OC)C1=CC=C(OC(CCCCCCC(NO)=O)=O)C=C1


		Search